Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.crmeth.2021.100011 http://scihub22266oqcxt.onion/10.1016/j.crmeth.2021.100011 34235498!8114573!34235498     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cell+Rep+Methods 2021 ; 1 (2): 100011 Nephropedia Template TP {{tp|p=34235498|t=2021. Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies |pdf=|usr=}}{{34235498}} gab.com Text Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies JO: Cell Rep Methods http://www.kidney.de/pget.php?&tw=1&pmid=34235498 #FOAvip We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and approximately 98% sensitivity. Furthermore, we found that the strength of the S-RBD antibody response measured by the agglutination assay correlated with the efficiency of the plasma in blocking RBD binding to the angiotensin-converting enzyme 2 in a surrogate neutralization assay, suggesting that the agglutination assay might be used to identify individuals with virus-neutralizing antibodies. Intriguingly, we found that >92% of patients had detectable antibodies on the day of a positive viral RNA test, suggesting that the agglutination antibody test might complement RNA testing for the diagnosis of SARS-CoV-2 infection. Twit Text FOAVip Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies ????Cell Rep Methods http://www.kidney.de/pget.php?&tw=1&pmid=34235498 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34235498 #FOAvip English Wikipedia <ref>{{Cite pmid|34235498}}</ref> Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies #MMPMID34235498 Esmail S; Knauer MJ; Abdoh H; Voss C; Chin-Yee B; Stogios P; Seitova A; Hutchinson A; Yusifov F; Skarina T; Evdokimova E; Ackloo S; Lowes L; Hedley BD; Bhayana V; Chin-Yee I; Li SS Cell Rep Methods 2021[Jun]; 1 (2): 100011 PMID34235498show ga We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid protein of SARS-CoV-2 with 100% specificity and approximately 98% sensitivity. Furthermore, we found that the strength of the S-RBD antibody response measured by the agglutination assay correlated with the efficiency of the plasma in blocking RBD binding to the angiotensin-converting enzyme 2 in a surrogate neutralization assay, suggesting that the agglutination assay might be used to identify individuals with virus-neutralizing antibodies. Intriguingly, we found that >92% of patients had detectable antibodies on the day of a positive viral RNA test, suggesting that the agglutination antibody test might complement RNA testing for the diagnosis of SARS-CoV-2 infection. |*COVID-19/diagnosis[MESH] |*SARS-CoV-2[MESH] |Agglutination[MESH] |Antibodies, Viral[MESH] |Humans[MESH]Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodi(epmc).pdf DeepDyve Pubget Overpricing